Stem cells and neurodegenerative diseases

Antonella Consiglio

POSTDOCTORAL RESEARCHERS
  • Meritxell Pons Espinal
  • Juan Pablo Muñoz Neculman
  • Aurora Scrivo
PREDOCTORAL RESEARCHERS
  • Jara Montero Muñoz
  • Neus Otero Fornes
  • David Piñol Belenguer
  • Valentina Baruffi
  • Veronica Testa
SCIENTIFIC SUPPORT
  • Irene Fernández Carasa
STUDENTS
  • Mariona Sunyer De Garaizabal
  • Neus Tort Boter
  • Monica Belles Fernandez
Neuroscience
Neuroscience

Scientific production

5

PAPER

Average IF: 5,26

4

LED PAPERS

Average IF: 5,85

4 PUBLICATIONS IN FIRST QUARTILE

5 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Hu,HB;Serra,C;Zhang,WJ;Scrivo,A;Fernández Carasa,I;Consiglio,A;Aytes,A et al, Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite, Cell Chem Biol, 2024;31(5):doi:10.1016/j.chembiol.2024.01.007
  • Pons Espinal,M;Blasco Agell,L;Fernandez Carasa,I;Andrés Benito,P;di Domenico,A;Richaud Patin,Y;Baruffi,V et al, Blocking IL-6 signaling prevents astrocyteinduced neurodegeneration in an iPSCbased model of Parkinson’s disease, JCI Insight, 2024;9(3):doi:10.1172/jci.insight.163359
  • Pons Espinal,M;Blasco Agell,L;Fernandez Carasa,I;Andrés Benito,P;di Domenico,A;Richaud Patin,Y;Baruffi,V et al, Blocking IL-6 signaling prevents astrocyteinduced neurodegeneration in an iPSCbased model of Parkinson’s disease, JCI Insight, 2024;9(3):doi:10.1172/jci.insight.163359
  • Jung Kc,K;Tristán Noguero,A;Altankhuyag,A;Belenguer,DP;Prestegård,KS;Fernandez Carasa,I;Baldeshi,AC et al, Tetrahydrobiopterin (BH4) treatment stabilizes tyrosine hydroxylase: Rescue of tyrosine hydroxylase deficiency phenotypes in human neurons and in a knock-inmouse model, J Inherit Metab Dis, 2024;47(3):494-508, doi:10.1002/jimd.12702
  • Manubens-Gil L, Pons-Espinal M, Gener T, Ballesteros-Yañez I, de Lagrán MM, Dierssen M. Deficits in neuronal architecture but not over-inhibition are main determinants of reduced neuronal network activity in a mouse model of overexpression of Dyrk1A. Cereb Cortex. 2024 Jan 14;34(1):bhad431. doi: 10.1093/cercor/bhad431
PROJECTS

1 Granted competive project
5 Ongoing competive projects

1 Started non competive project
2 Ongoing non competive projects

INNOVATION

1 Patent

PUBLISHED WORKS

2 Theses

NETWORKS

SGR GRC-2021

Selected projects

  • 2022 BP 00242. 2022 BP 00242 -SCRIVO. AGENCIA GESTIO D’AJUTS UNIV. I RECERCA. Budget: 152.348,46€. 2024-2027. PI: CONSIGLIO, ANTONELLA.
  • 202012-32. Developing patient-tailored therapeutic candidates for rare genetic forms of pediatric Parkinsonism. Fundació La Marató de TV3. Budget: 134.252,47€. 2021-2024. PI: CONSIGLIO, ANTONELLA.
  • 202012-32. Developing patient-tailored therapeutic candidates for rare genetic forms of pediatric parkinsonism. Fundació La Marató de TV3 . Budget: 102.000€. 2021-2024. PI: CONSIGLIO, ANTONELLA.
  • LCF/BQ/DI21/11860038. INPHINIT – INCOMING. FUNDACIÓ “LA CAIXA”. Budget: 115.092€. 2021-2024. PI: CONSIGLIO, ANTONELLA.
  • CI24-20499. NeurAntigen: A human Neural Method for the Diagnosis of Autoimmune Encephalites. FUNDACIÓ “LA CAIXA”. Budget: 76.835€. 2024-2026. PI: CONSIGLIO, ANTONELLA.